The metabolism of chylomicron remnants and VLDL was studied in healthy controls and normo-(NTG) and hypertriglyceridemic (HTG) patients with coronary artery disease after intake of an oral fat load. Specific determination of apo B-48 and B-100 enabled separation of the respective contribution of the two lipoprotein species. The postprandial plasma levels of small (Sf 20-60) and large (Sf 60-400) chylomicron remnants increased in controls and NTG patients. In contrast, only large chylomicron remnants increased in the HTG patients. An increase of large VLDL was seen in response to the oral fat load in all groups, whereas small VLDL were either unchanged in the controls and the NTG patients, or decreased in the HTG patient group. The whole plasma concentration of C apolipoproteins was essentially uninfluenced by the oral fat load, whereas the content in large triglyceride-rich lipoproteins paralleled the apo B elevations in controls and NTG patients. An even more prominent increase of apo B in large triglyceriderich lipoproteins in the HTG group was not accompanied by an increase of C apolipoproteins. These findings indicate that chylomicrons compete with VLDL for removal of triglycerides by lipoprotein lipase and that the postprandial metabolism of triglyceride-rich lipoproteins is severely defective in hypertriglyceridemia. (J. Clin. Invest. 1993.91:748-758.) Key words: chylomicron remnants * very low density lipoprotein -apolipoprotein B-48 * apolipoprotein B-100 * apolipoprotein C-I1
Introduction
Triglyceride-rich lipoproteins (TGRL)' are a heterogeneous population of lipoprotein particles varying in site of synthesis, structure, and metabolism. VLDL are made in the liver and contain apo B-100 and endogenous lipids. By contrast, ingestion of fat leads to production ofchylomicrons containing apo B-48 in the intestine. Synthesis of apo B-100 has recently also been described in the human gut; the quantitative significance of this is, however, still unknown (1) . The apo B molecule remains an integral part ofthe lipoprotein particle, whereas the triglyceride content of TGRL is readily hydrolyzed by lipoprotein lipase (LPL) resulting in formation of remnant particles (2) . The family of apo Cs (C-I, C-II, and C-III) and apo E are thought to be transferred from HDL to TGRL during alimentary lipemia (3) . Triglyceride hydrolysis by LPL requires apo C-II as cofactor. The roles of apo C-I and C-Ill in the metabolism of TGRL are less well understood. Apo C-Ill has been considered both to counteract the lipolysis stimulating function of apo C-Il (4, 5) and to inhibit the receptor-mediated uptake of TGRL (6) (7) (8) . The same opposing effect on receptormediated uptake of remnant lipoprotein particles has been shown for apo C-I in vitro (9) . Apo E serves as a ligand for binding of TGRL to cellular receptors (10, 1 1). The amount and conformation of apo E has been shown to be of major importance for cell mediated uptake of hypertriglyceridemic (HTG) VLDL in vitro (10) . The isoform ofapo E has also been shown to influence the elimination of chylomicron remnants from plasma (12, 13) . In particular, the presence of apo E2 delays the clearance of chylomicron remnants. Under normal metabolic conditions, LDL is the end product of the metabolism of VLDL in humans. On the other hand, since no apo B-48 is found in LDL, chylomicrons and their remnants are thought to be removed from plasma earlier in the lipolytic cas- cade. Because the metabolic end products ofTGRL are considered to be involved in atherogenic processes, studies ofalimentary lipemia is of major clinical interest (14) .
Most previous studies on chylomicron and chylomicron remnant metabolism in humans have used retinyl palmitate as a marker for intestinally derived TGRL (15) (16) (17) . A delayed clearance of chylomicron remnants has been found in subjects with manifest coronary artery disease (CAD) (18) (19) . Direct quantification of chylomicron remnants and VLDL by determination of apo B-48 and apo B-100 in TGRL during alimentary lipemia has, however, not been performed before. Therefore we have investigated the generation and catabolism of postprandial chylomicron remnants and the impact ofalimentary lipemia on VLDL metabolism in control subjects and in normotriglyceridemic (NTG) and HTG patients with manifest CAD. This was done by conducting an oral fat tolerance test with direct quantification of apo B-48 and B-100 in subfractions of TGRL of different particle size. The impact of some components of lipoprotein particle composition and the influence oflipolytic enzymes were assessed by determining the apo C-I, C-Il, C-HII, and E concentrations in subfractions ofTGRL, the apo E genotypes, and the activities of postheparin plasma LPL and hepatic lipase (HL).
Methods
Patients and controls. A total of 32 patients with angiographically ascertained CAD who had all survived a first myocardial infarction before the age of 45 yr and who had subsequently participated in an angiographic study of mechanisms associated with progression ofcoro-nary atherosclerosis (20) were enrolled into the study. Patients with polygenic or monogenic hypercholesterolemias (based on repeated lipoprotein classifications showing a type Ila pattern and studies of firstdegree relatives) were not considered. Subjects who were obese (2 130% ideal weight), or had manifest diabetes mellitus (repeated fasting blood glucose values 2 7.0 mmol/liter), or were taking lipid-lowering medication or abusing alcohol were excluded. Due to these exclusion criteria the patient group comprised 14 normolipidemic subjects and 3 NTG subjects with sporadic hypercholesterolemia and 15 subjects with mild to moderate HTG. Lipoprotein phenotyping was based on the 90th percentiles of VLDL triglyceride (1.65 mmol/liter) and LDL cholesterol (5.35 mmol/liter) values in an age-and sex-matched control population (21) . None ofthe patients studied had suffered reinfarction within the preceding 6 mo. Coronary artery bypass grafting had been performed on nine patients with severe exertional angina. More than 1 yr had elapsed between bypass surgery and the present study. A control group comprising 10 normolipidemic men of similar age was recruited from participants in a previous population survey (21) . They had initially been drawn from a register containing all subjects permanently living in the county. All controls were free of symptoms and clinical signs of CAD. There was no clinical or laboratory evidence of thyroid dysfunction or other conditions leading to secondary hyperlipoproteinemia in any of the patients or controls studied.
At the time of their myocardial infarction all patients were instructed to follow a diet low in fat, rich in complex carbohydrates, and with a limited intake of alcohol. The percentage composition of the different sources of energy in the recommended diet was 10-15% protein, 30% fat, and the remaining energy from carbohydrates. The ratio of saturated to mono-and polyunsaturated fat was 1:1:1.
Oralfat tolerance test. Participants were admitted early in the morning to the Clinical Research Unit for a mixed meal type of oral fat tolerance test. They had been fasting for 12 h and asked to refrain from smoking during the fasting period and from alcohol intake during the preceding 3 d. The protocol for the fat tolerance test was a slight modification ofthat ofCohn et al. (22) . An emulsion consisting ofsoybean oil (50 g/m2 body surface area [23] ; Karlshamns Oils & Fats AB, Karlshamn, Sweden), glucose (50 g/m2), egg-white protein (0500, 25 g/m2; Sigma Chemical Co., St. Louis, MO), dried egg yolk (0625, 6.3 g/m2; Sigma), and 200 ml water prepared with some lemon flavor (60.2% fat, 13.3% protein, and 26.5% carbohydrate by energy) was ingested within 10 min between 7:00 and 7:30 a.m. The test meal was well tolerated by all subjects. Blood samples were obtained through an indwelling catheter. A fasting blood sample was taken before intake of the test meal. Subsequent blood samples were drawn hourly for the first 9 h and the last sample was taken 12 h after ingestion ofthe emulsion. Participants were allowed to be ambulant throughout the test. Smoking was not allowed. Water, but no food, was allowed during the test.
Blood sampling. Venous blood samples were drawn into precooled sterile tubes (Vacutainer; Becton Dickinson, Meylan Cedex, France) containing Na2EDTA (1.4 mg/ml), which were instantly put into icewater. Plasma was then recovered within 30 min by low speed centrifugation (1,750 g, 20 min, + 1 0C) and kept at this temperature throughout the preparation procedures. NaAzide (1.0 mol/liter), PMSF (10 mmol/liter, dissolved in isopropanol), and aprotinin (1,400 /g/ml) (Trasylol; Bayer, Leverkusen, Germany) were immediately added to the isolated plasma before fractionation of TGRL to final concentrations of 1.0 mmol/liter, 10 tmol/liter, and 28 ,ug/ml, respectively. Subfractionation ofSf> 12 lipoproteins. TGRL were subfractionated by cumulative rate ultracentrifugation (24) from plasmas drawn before ingestion of the test meal and 3, 6, and 12 h thereafter. Plasma was adjusted to density 1. 10 kg/liter with solid NaCl. A density gradient consisting of4 ml of 1.10 kg/liter plasma and 3 ml each of 1.065, 1.020, and 1.006 kg/liter NaCl solutions was then formed in tubes (vol 13.4 ml) (Ultraclear; Beckman Instruments, Inc., Fullerton, CA) which had been coated with polyvinyl alcohol (BDH Chemicals Ltd., Poole, UK Biotechnology AB). Graphs relating the intensity of staining (area under the scanning curve) for the apo B-48 and B-100 peaks to the lipoprotein sample dilution were constructed. The relative amounts of the two molecular forms of apo B in the sample could then be calculated. The absolute masses of apo B-48 and B-100 were derived from their relative quantities and the total apolipoprotein B mass. The latter was quantified in all fractions ofTGRL and in the Sf 12-20 fraction by electroimmunoassay after pretreatment of samples with lipase (29) . The intra-and interassay coefficients of variation were 2.7 and 2.1% respectively, for the two molecular forms of apo B (25) . The lower quantification limit on the gel was 2 Mg apo B.
Determination ofapo C-I, C-II, C-III, and E. Whole plasma concentrations and concentrations ofapo C-I, C-II, C-Ill, and E oflipoprotein fractions (Sf> 400, Sf 60-400, Sf 20-60 and Sf 12-20) were determined in triplicate by an enzyme immunoassay (30) . The validity of this method for use on postprandial plasma lipoproteins has been demonstrated previously (31) .
Apo E genotyping. DNA was extracted from fresh blood samples by the Triton X-100 lysis method (32) . The restriction isotyping procedure (PCR amplification on an intelligent heating block [Cambio, Cambridge, UK], digestion with the enzyme HhaI, and electrophoresis on polyacrylamide gels) was then applied as described by Hixson and Vernier (33) . Oligonucleotide primers used in the PCR were as previously described (34) .
Determination ofLDL and HDL. The cholesterol and triglyceride content of LDL and HDL was determined by a combination ofpreparative ultracentrifugation and precipitation of apo B-containing lipoproteins followed by lipid analyses as described (35) . The "LDL fraction" determined by this method is actually composed of intermediate density lipoprotein and LDL and may contain lipoprotein (a). Lipid analyses. Total cholesterol and triglycerides were determined in triplicate in plasma and in the major plasma lipoproteins. For quantification of cholesterol and triglycerides in plasma, HDL, and LDL, lipids were first extracted with chloroform-methanol (36 
Results
Basic characteristics ofthe study groups. The distribution of subjects between apo E genotypes and oral glucose tolerance categories, postheparin plasma lipase activities, and body mass indices are shown in Table I . The apo E 3/3 genotype dominated in all groups. Seven subjects were heterozygous for the apo E2 allele, three belonged to the control group, three to the NTG patient group, and one to the HTG patient group. There were no subjects homozygous for the E2 allele. No subject with decreased oral glucose tolerance was found in the control group, whereas two NTG and six HTG patients had decreased oral glucose tolerance. Postheparin plasma LPL activity was significantly lower in the HTG patient group than in the NTG patient and the control groups. In contrast, the HTG subjects had significantly higher HL activity compared with the NTG patient group. The body mass index was somewhat higher in the HTG patient group.
Fastingplasma lipoproteins. Plasma concentrations ofcholesterol, triglyceride, apo B-100, and apo B-48 in TGRL, and plasma concentrations of cholesterol and triglycerides in LDL and HDL are given in Table II . The levels of cholesterol, triglyceride, and apo B-100 were markedly elevated in the fractions containing large (Sf60-400) and small (Sf20-60) TGRL particles in the HTG group as a consequence of the criteria for selection of the HTG patients. The large TGRL particles in the HTG patient group appeared to be enriched in both cholesterol and triglyceride, since the ratios between lipid parameters and apo B-100 were elevated when compared with these ratios in the controls and the NTG patients. The apo B-100 concentration in the Sf 12-20 range, namely the IDL particle number, Postprandial responses oftriglyceride-rich lipoproteins. The plasma concentrations of triglycerides, apo B-48, and apo B-100 in TGRL after intake of the oral fat load are shown in Table III and illustrated further in Fig. 1 . The fasting and postprandial plasma concentrations of apo B-48 in the Sf > 400 fraction were frequently low and quantification could only be made in 18:42 subjects (data not shown). Similarly, triglyceride levels in the Sf > 400 fraction of fasting plasma were low in all groups. 3 h after intake of the fat load the triglyceride concentration in Sf > 400 lipoproteins was markedly elevated in the HTG group compared with the control and NTG patient groups and had increased even further at 6 h, whereas the level was unchanged between 3 and 6 h in the NTG group and re- duced at 6 h in the control group. Base line levels were attained in all groups 12 h after the fat load. The pattern of triglyceride elevation induced by the oral fat load in the Sf 60-400 lipoprotein fraction was similar to the Sf > 400 lipoprotein fraction. The triglyceride concentrations in the 3-and 6-h plasma samples were two to three times higher in the HTG group than in either controls or the NTG patients. The Sf 60-400 apo B-48 concentration of the HTG patients increased to twice that in the control group at 3 h. The peak of apo B-48 appeared to be around 3 h in the control group, between 3 and 6 h in the NTG patient group, and around 6 h in the HTG patient group. Thus, the response of apo B-48 was both prolonged and exaggerated in the HTG patient group.
The apo B-l00 concentration almost doubled between the fasting and the 3-h sample in all groups and remained at this level at 6 h in both the NTG and the HTG patient groups, whereas a reduction was seen in the control group. Base line, or even lower than base line levels, were attained at 12 h in all groups.
The triglyceride concentration of the Sf 20-60 fraction was not influenced by the oral fat load in any ofthe study groups. A statistically significant rise in apo B-48 was seen at 3 h in the control group and both at 3 and 6 h in the NTG patient group.
In contrast, there was no increase in apo B-48 by the oral fat load in the HTG subjects, in whom the apo B-48 concentration was significantly elevated already in the fasting plasma sample. Concerning the apo B-100 response in the Sf 20-60 fraction, the postprandial level was unchanged in the control and NTG patient groups, whereas a reduction was seen 3 h after intake of the oral fat load in the HTG patient group. The base line level was attained at 12 h in the HTG group.
The triglyceride and apo B-48 concentrations in the Sf 12-20 fraction remained unchanged throughout the test in all groups, whereas a significant reduction of apo B-100 was seen at 3 h in the control group and at both 3 and 6 h in the NTG and HTG patient groups.
Apo C-I, C-II, C-III, andE in whole plasma during the oral fat tolerance test. The whole plasma concentrations of apo C-I, C-Il, C-Ill, and E in fasting samples and after intake of the oral fat load are shown in Table IV . For the concentrations of apo C-I, there were no statistically significant differences between the groups at any time point. The levels were essentially unchanged at 3 and 6 h after intake of the oral fat load, whereas a consistent decrease of -15% was seen at 12 h in all groups. The fasting plasma concentrations of apo C-Il and C-III were highest in the HTG group. No major changes were seen at 3 and 6 h in either patients or controls, while a decrease ranging between 10 and 30% was found at 12 h in all groups. For apo E, similar to apo C-I, C-Il, and C-Ill, the fasting plasma concentration was increased in the HTG group and a decrease was observed at 12 h in all groups.
Apo C-I, C-Il, C-III, and E in triglyceride-rich lipoproteins during the oralfat tolerance test. Plasma concentrations of apo C-I, C-II, C-Ill, and E in TGRL in fasting samples and after intake of the oral fat load are shown in Table V . In fasting samples the HTG group had elevated levels of apo C-I, C-Il, C-III, and E in the Sf 60-400 and Sf 20-60 fractions. The ratios of apo Cs and E to apo B (apo B-48 + apo B-100) were elevated in the Sf 60-400 fraction of the HTG patients compared to both NTG patients and controls (Tables III and V) . In contrast, the corresponding ratios were similar for the Sf 20-60 fraction in all groups. Only trace amounts were found in the Sf > 400 fraction of fasting samples and low levels, occasionally close to the limit of quantification, were measured in postprandial samples of this fraction. In the Sf 60-400 lipoprotein fraction major elevations of apo C-I and E were induced by the oral fat load in all groups. The relative increments of apo C-I and E resembled those of apo B-48, apo B-100, and triglycerides in this fraction. The levels of apo C-II and apo C-Ill in the control group were doubled at 3 h, subsequently reduced at 6 h, and reached base line level at 12 h. In the NTG patient group, the levels of apo C-Il and apo C-III were increased at both 3 and 6 h, in parallel with the apo B-48, apo B-100, and triglyceride concentrations. In contrast, there was no significant postprandial increment of the mean apo C-Il level in the Sf 60-400 fraction among HTG patients. An insignificant increase of apo C-Ill was seen at 3 h in these subjects.
The oral fat load failed to induce changes in the concentrations of apo C-I, C-II, C-Ill, or E in the Sf 20-60 lipoprotein fraction in either the controls or the NTG patients. Decreases by -50% of apo C-II and C-Ill were found at both 3 and 6 h in the HTG patient group.
The relative changes in triglycerides, apo C-IL, and the sum of apo B-48 and apo B-100 in the Sf 60-400 fraction in the three groups are shown in Fig. 2 . In the controls and the NTG (12) and hyperlipidemic subjects (18, 41) , and in patients with CAD and no lipoprotein abnormalities ( 19) .
To the best of our knowledge direct quantification of apo B-48 and apo B-100 in subfractions of postprandial TGRL has not been performed previously. Our data suggest that chylomicron remnants appear in plasma soon after intake ofan oral fat load. All apo B-48-containing lipoproteins in the Sf 60-400 fraction are not necessarily chylomicron remnants, since secretion of chylomicrons into this fraction cannot be entirely ruled out. However, in this work chylomicron remnants and Sf 60-400 lipoproteins containing apo B-48 were equated. In NTG subjects, increases in the concentrations of both large (Sf 60-400) and small (Sf 20-60) chylomicron remnants occurred in response to the oral fat load. In contrast, the HTG patients responded with increased plasma levels of large chylomicron remnants only, whereas no change was seen in the small chylomicron remnant fraction, which in this group was clearly elevated already in the fasting state. This implies a profound defect in the metabolism of chylomicron remnants in hypertriglyceridemia. Turnover studies of VLDL have shown that HTG VLDL to a large extent is cleared from the circulation as large VLDL (42) . Our findings suggest that this may also be true for large chylomicron remnants.
The increase of large chylomicron remnants was accompanied by elevation of large (Sf 60-400) VLDL in all study groups [12] [13] [14] [15] [16] [17] [18] [19] [20] fraction in all study groups support the notion ofdelayed degradation of VLDL during alimentary lipemia. However, the data should be interpreted with due caution since neither the rates of conversion nor the rates of clearance ofapo B-100 in TGRL and their dependence on plasma levels were actually measured.
A massive increase of apo B-48 and a limited increase of apo B-100 in the TGRL fraction has been demonstrated previously in healthy subjects by Cohn et al. (22) , who concluded that both the liver and the intestine contribute to postprandial triglyceridemia. However, in their study the total TGRL fraction was delipidated and separation ofapolipoproteins was performed with SDS-PAGE. The increases ofapo B-48 and B-I00 were expressed in relation to the fasting levels. Cohn et al. subsequently studied the effect of fasted and fed conditions on the synthetic rate of VLDL apo B-100 using a sensitive isotope dilution technique (44) . They concluded that the synthesis of VLDL apo B-100 increased by -50% in fed compared with fasted individuals. However, the possible effect of competition in the lipolytic system between newly synthesized chylomicrons and VLDL was not taken into account in their analysis.
An alternative hypothesis to explain the VLDL elevation during alimentary lipemia should also be pointed out. In tracer studies of TGRL it is often seen that the plasma volume upon reinjection of radioiodinated VLDL is smaller than the initial plasma volume calculated by an isotope dilution technique (45) . One reason for this phenomenon might be that TGRL undergoing lipolysis are attached to LPL bound to the endothelium and are not evenly distributed in plasma. If a better substrate for LPL appears, then the previously bound TGRL are released with a subsequent increase in plasma concentration. Generation of chylomicrons and chylomicron remnants can thus hypothetically reduce the "margination" of VLDL.
The fasting plasma levels ofcholesterol in the Sf60-400, Sf 20-60, and Sf 12-20 fractions were increased in the HTG patients, and on a per particle basis, the cholesterol content was clearly elevated in these fractions in the HTG subjects. This finding has been documented in previous studies (46) . Since chylomicron remnants and VLDL particles were not isolated, no valid assessment of particle composition could be made on postprandial plasma samples.
Degradation of TGRL triglycerides is catalyzed by LPL. However, no consistent associations were observed between postheparin LPL activity and the AUCs for apo B-48 or apo B-100 in the Sf 60-400 fraction taken as a measure of the postprandial levels of large chylomicron remnants and large VLDL particles, respectively. This is in agreement with the observations by Weintraub et al. (16) . Although they found negative correlations between the postheparin plasma LPL ac- Table V T  T  T  T  2±1  13±17  14±8  1±1  3±2  9±7  13±6  3±3  3 h  1±1  2±1  6±3  1±1  11±12  24±12  39±21  3±2  4±2  8±5  11±8 The members of the apo C family have been assigned important roles in the metabolism of TGRL. An altered distribution ofapo C-II in HTG VLDL was first demonstrated by Kane et al. (49) and later confirmed by others (50) . It was found that HTG VLDL had a reduced ratio of apo C-II to total VLDL protein and therefore concluded that this might contribute to the impaired catabolism of HTG VLDL. Reduced whole plasma levels of apo C-I1 and C-IIl in the postprandial state have also been reported previously (51) . It has been speculated Postprandial Triglyceride-rich Lipoproteins 755 ., apo C-II.
that apo Cs leave the plasma compartment together with the TGRL remnants which are formed during lipolysis (51, 52) . Quantification of apo C-Il and C-Ill in the TGRL fractions showed that the concentrations of these apolipoproteins in large and small TGRL in NTG subjects tended to parallel the content of triglyceride, apo B-48, and apo B-100 in each fraction. This suggested a constant molar ratio between apo C-II, C-III, and B, and triglycerides. In contrast, the postprandial influx of apo B-48, apo B-100, and triglycerides into the Sf 60-400 fraction was not paralleled by increased levels of apo C-Il and C-Ill in HTG subjects. Furthermore, the apo C-II and C-Ill concentrations of Sf 20-60 TGRL were reduced in HTG subjects. This indicates that HTG subjects acquire an altered apolipoprotein composition of Sf 20-60 and Sf 60-400 lipoproteins during alimentary lipemia.
Recently, Iriyama et al. (53) suggested that the capacity of HDL for donating apo Cs to TGRL is limited in experimental hypertriglyceridemia. It can thus be speculated that a relative deficiency of apo C-II and C-Ill ensues in the HTG TGRL as indicated in the present study. The implication would be that the apo C content of plasma HDL that can be transferred to postprandial TGRL may influence the metabolism of HTG TGRL particles. Assuming that the absence of any increase in the concentration of apo B-48 in the Sf 20-60 fraction in HTG subjects is a sign of reduced conversion of large chylomicron remnants to smaller remnant species, this disturbance may partly depend on excessive unmasking of apo E, due to low levels of apo C-III, with a subsequent increase in receptor mediated uptake of large chylomicron remnants (6) (7) (8) (9) . Furthermore, the accumulation of large TGRL might also be secondary to decreased availability of apo C-II, the cofactor for LPL, with effects on the delipidation of the large TGRL species.
In conclusion, the present study demonstrates that postprandial triglyceridemia is not solely accounted for by the generation of intestinally derived chylomicrons and chylomicron remnants. A major contribution of presumably liver-derived TGRL was seen in all study groups. Importantly, the TGRL of the HTG patients were shown to acquire an abnormal apolipoprotein composition during alimentary lipemia. The elevated plasma levels and the altered composition of large TGRL during alimentary lipemia in HTG individuals influence the metabolism of cholesterol-rich smaller lipoproteins particles (chylomicron remnants and VLDL) which are presumably involved in atherogenesis (54) . 
